1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsRecovery Housing and Recovery Support Services for Young Adults (Pennsylvania) is sponsored by Pennsylvania Department of Drug and Alcohol Programs (DDAP). This opportunity supports mission-aligned projects and measurable outcomes.
Get alerted about grants like this
Get emailed when new opportunities from “Pennsylvania Department of Drug and Alcohol Programs (DDAP)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
DDAP Awards Nine Grants Totaling $1. 2 Million to SCAs for Recovery Housing, Supports for Young Adults Jason Snyder • January 27, 2026 DDAP Awards Nine Grants Totaling $1. 2 Million to SCAs for Recovery Housing, Supports for Young Adults The Pennsylvania Department of Drug and Alcohol Programs (DDAP) is awarding more than $1.
2 million to expand access to recovery housing and recovery support services throughout Pennsylvania for young adults 18–24 years old who have opioid or stimulant use disorders. DDAP is awarding grants to nine Single County Authorities (SCA) to fund the effort. Currently, there are about 430 DDAP-licensed recovery houses across the Commonwealth.
The purpose of the Administration’s licensure program is to help empower sustained recovery for individuals with substance use disorder (SUD) by ensuring a network of safe drug and alcohol recovery houses. Drug and alcohol recovery houses are required to be licensed in order to receive referrals from state agencies or state-funded facilities or to receive federal or state funding to deliver recovery house services.
The grant funds will be used to supplement existing resources, ensuring that current services are expanded rather than replaced, and that recovery housing remains accessible and safe through Pennsylvania.
DDAP is awarding nine grants, which will run through September 30, 2026, to the following SCAs serving 14 counties: Berks County Council on Chemical Abuse: Berks County Blair County Drug and Alcohol Program, Inc.: Blair County Columbia Montour Snyder Union Drug & Alcohol Services: Columbia, Montour, Snyder, and Union Counites Delaware County Department of Human Services, Division of Drug and Alcohol Programs: Delaware County Erie County Office of Drug and Alcohol Abuse: Erie County Lackawanna/Susquehanna Office of Drug and Alcohol Programs: Lackawanna and Susquehanna Counties Somerset Single County Authority for Drug and Alcohol: Somerset County Westmoreland Drug & Alcohol Commission, Inc.: Westmoreland County York Adams Drug and Alcohol Commission: York and Adams Counties Read the full press release .
RCPA Shares Initial 2026/27 Budget Overview RCPA has provided members a general update on the Pennsylvania 2026/27 budget. Further updates will be given at the next Government Affairs Committee meeting. MyODP News Online Digest — July 10, 2026 ODP has shared the MyODP News Online Digest for July 10, 2026.
RCPA Member Familylinks, Inc. Announces Affiliation With Life'sWork Life’sWork of Western PA has become an affiliate partner of Familylinks, Inc., effective July 1, 2026. Rehabilitation & Community Providers Association
According to the current listing, eligibility includes: Nine Single County Authorities (SCAs) in Pennsylvania serving 14 counties were awarded grants. Organizations seeking funding would typically work through their respective SCA. Confirm the full requirements in the official notice before applying.
Applications for Recovery Housing and Recovery Support Services for Young Adults (Pennsylvania) are due September 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Recovery Housing and Recovery Support Services for Young Adults (Pennsylvania) is funded by Pennsylvania Department of Drug and Alcohol Programs (DDAP). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Pennsylvania. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleARPA-H's FASTPASS program targets a public-health blind spot: substandard and contaminated drugs that are only caught after patients are exposed. It funds through-package chemical sensing (TA1 SAMPLE) and the analytics to act on it (TA2 DETECT). The solicitation posts to SAM.gov in mid-August 2026, with a virtual Proposer Workshop on August 24 and registration closing August 20. Here is what FASTPASS funds, why the timing matters, and how to position a cross-disciplinary team.
Read articleARPA-H PROSPR program funds seven research teams testing rapamycin, semaglutide, and novel compounds to extend healthspan. A deep analysis of the science, the money, and what it means for the field.
Read article